Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO 
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission 
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 
Novartis M&A Strategy Faces Investor Scrutiny After Drug Setbacks 
Should I take zinc or eat oysters to ward off colds, boost my immune system or improve fertility? 
China vs. NASA: The New Moon Race and What's at Stake by 2030 
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations 
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds 
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
France Battles Mediterranean Wildfires as Heatwave Fuels Fire Risk 
U.S. Issues Cuba Health Alert as Illnesses Rise 
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise 
Add as a preferred source on Google
As of now, there is still no definitive cure for coronavirus and scientists are scrambling to find and develop a cure. Papua New Guinea is also on the search for a cure as its government has allocated $3 million to an unknown firm to find a possible COVID-19 cure.
Papua New Guinea has given $3 million to a company known as Niugini BioMed Ltd., which was established back in August. The funds will be used for research to discover a possible cure for COVID-19 from existing drugs. This report was found from leaked documents in contrast to Prime Minister James Marape saying that the country’s national executive council has not yet completed its approval process to assign a company to find a possible COVID-19 cure.
So far, a team from the University of Papua New Guinea was claimed to have looked through 30,000 known drugs all over the world to identify 10 possible COVID-19 treatments. The cabinet submission that presented the claim was also signed by Marape, will instruct the ministers, its treasury, and finance to give $10.2 million kinas or around $2.8 million. The submission also instructs its health department to collaborate with the company assigned to start running clinical trials.
“We have young and competent PNG scientists, who have presented their case to the COVID-19 controller...and our medical and science community, that they may be on to something big,” said Marape. “It may be true, or vice-versa, but I am not a prime minister to kill ingenuity, research, science, and study.”
Meanwhile, in the United States, a $375 million deal was brokered with company Eli Lilly to provide 300,000 doses of its experimental antibody drug to possibly treat COVID-19. The deal details that the company has two months to deliver the doses after being given an emergency use authorization by the Food and Drug Administration. It also gives the government an option to buy 650,000 more doses all the way through June 30, said the company.
Eli Lilly filed a request to the FDA this month for an emergency use authorization of its drug to be used on COVID-19 patients with mild to moderate cases.
